Joel Greenblatt's NGVT Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 25,132 shares of Ingevity Corporation (NGVT) worth $1.49 M, representing 0.01% of the portfolio. First purchased in 2016-Q4, this long-term strategic position has been held for 31 quarters.
Based on 13F filings, Joel Greenblatt has maintained a strategic position in NGVT, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2020, adding 65,551 shares. Largest reduction occurred in Q2 2017, reducing 57,192 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Ingevity Corporation (NGVT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Ingevity Corporation (NGVT) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -16,401 | Reduce 39.49% | 25,132 | $59.18 |
| Q3 2025 | +11,695 | Add 39.19% | 41,533 | $55.19 |
| Q2 2025 | +7,529 | Add 33.75% | 29,838 | $43.09 |
| Q1 2025 | -7,060 | Reduce 24.04% | 22,309 | $39.59 |
| Q4 2024 | +16,765 | Add 133.01% | 29,369 | $40.75 |
| Q3 2024 | +148 | Add 1.19% | 12,604 | $39.00 |
| Q2 2024 | +4,554 | Add 57.63% | 12,456 | $43.71 |
| Q1 2024 | +2,646 | Add 50.34% | 7,902 | $47.70 |
| Q4 2023 | +5,256 | New Buy | 5,256 | $47.22 |
| Q2 2023 | -4,907 | Sold Out | 0 | $0.00 |
| Q1 2023 | -6,930 | Reduce 58.55% | 4,907 | $71.52 |
| Q4 2022 | +5,437 | Add 84.95% | 11,837 | $70.44 |
| Q3 2022 | +1,281 | Add 25.02% | 6,400 | $60.62 |
| Q2 2022 | -5,916 | Reduce 53.61% | 5,119 | $63.10 |
| Q1 2022 | -6,163 | Reduce 35.84% | 11,035 | $64.07 |
| Q4 2021 | +646 | Add 3.90% | 17,198 | $71.69 |
| Q3 2021 | +3,970 | Add 31.55% | 16,552 | $71.35 |
| Q2 2021 | -1,809 | Reduce 12.57% | 12,582 | $81.39 |
| Q1 2021 | -3,385 | Reduce 19.04% | 14,391 | $75.53 |
| Q4 2020 | -10,819 | Reduce 37.84% | 17,776 | $75.72 |
| Q3 2020 | -36,956 | Reduce 56.38% | 28,595 | $49.45 |
| Q2 2020 | +65,551 | New Buy | 65,551 | $52.57 |
| Q1 2020 | -2,534 | Sold Out | 0 | $0.00 |
| Q4 2019 | +2,534 | New Buy | 2,534 | $87.21 |
| Q2 2018 | -5,037 | Sold Out | 0 | $0.00 |
| Q1 2018 | -18,481 | Reduce 78.58% | 5,037 | $73.65 |
| Q4 2017 | +19,772 | Add 527.82% | 23,518 | $70.46 |
| Q3 2017 | -4,296 | Reduce 53.42% | 3,746 | $62.47 |
| Q2 2017 | -57,192 | Reduce 87.67% | 8,042 | $57.45 |
| Q1 2017 | +4,348 | Add 7.14% | 65,234 | $60.84 |
| Q4 2016 | +60,886 | New Buy | 60,886 | $54.86 |
Joel Greenblatt's Ingevity Corporation Investment FAQs
Joel Greenblatt first purchased Ingevity Corporation (NGVT) in Q4 2016, acquiring 60,886 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Ingevity Corporation (NGVT) for 31 quarters since Q4 2016.
Joel Greenblatt's largest addition to Ingevity Corporation (NGVT) was in Q2 2020, adding 65,551 shares worth $3.45 M.
According to the latest 13F filing for Q4 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 25,132 shares of Ingevity Corporation (NGVT), valued at approximately $1.49 M.
As of the Q4 2025 filing, Ingevity Corporation (NGVT) represents approximately 0.01% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Ingevity Corporation (NGVT) was 65,551 shares, as reported at the end of Q2 2020.